Predictive Technology Group, Inc.

PRED

US74039H1023

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 07:23:03 17/07/2024 pm IST			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	-66.67%

10/06	Predictive Technology Group, Inc. Went Out of Business	CI
12/01	Motion For Case Conversion Approved for Predictive Technology Group, Inc.	CI

Predictive Technology Group, Inc. signed a letter of intent to acquire FlagshipHealth Group.

January 09, 2018

Predictive Technology Group, Inc. (OTCPK:PRED) signed a letter of intent to acquire FlagshipHealth Group on January 9, 2018.

Latest news about Predictive Technology Group, Inc.

Predictive Technology Group, Inc. Went Out of Business	10/06	CI
Motion For Case Conversion Approved for Predictive Technology Group, Inc.	12/01	CI
Motion for Case Conversion Filed by Predictive Technology Group, Inc.	14/12	CI
Subchapter V Trustee Appointed Under Chapter 11 for Predictive Technology Group, Inc.	15/11	CI
Predictive Technology Group, Inc. Filed for Bankruptcy	09/11	CI
Predictive Technology Group, Inc. Announces Resignation of Jacob Easdale as Chief Accounting Officer	08/21/08	CI
Predictive Technology Group, Inc. Announces Chief Financial Officer Changes	08/21/08	CI
Predictive Technology Group, Inc. Announces Executive Changes	12/21/12	CI
Predictive Technology Group, Inc. Entered into Strategic Development Agreement with Nebula Genomics	22/21/22	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	18/21/18	CI
Predictive Technology Group, Inc. Announces Executive Changes	18/21/18	CI
Predictive Technology Group, Inc. Announces Executive Changes	18/21/18	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020	17/21/17	CI
Predictive Technology Group, Inc. Enters into an Amendment and Termination Agreement with ProPhase	19/21/19	CI
Predictive Technology Group, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	17/20/17	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Full Year Ended June 30, 2020	21/20/21	CI
Predictive Technology Group, Inc. Auditor Raises 'Going Concern' Doubt	20/20/20	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2020	16/20/16	CI
Predictive Technology Group Announces Initial Order of One Million Units of the Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test from Distribution Partner, Wellgistics, LLC	08/20/08	CI
Predictive Technology Group and Jiangsu Dablood Pharmaceutical Co, Ltd. Provide Updates of its Assurance AB COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care	30/20/30	CI
Predictive Technology Group Announces Launch of Assurance AB COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care	25/20/25	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2019	15/20/15	CI
Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration	28/20/28	CI
Jay Moyes Resigns as a Director of the Predictive Technology Group, Inc	08/20/08	CI
Predictive Technology Group, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2019	15/19/15	CI

Chart Predictive Technology Group, Inc.

Duration

Period

More charts

Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the bodyâs natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Whartonâs Jelly umbilical cord-derived products to new heights.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PREDICTIVE TECHNOLOGY GROUP, INC.	-66.67%	31.67K
MODERNA, INC.	+24.74%	47.54B
IQVIA HOLDINGS INC.	-0.47%	41.96B
LONZA GROUP AG	+48.77%	41.55B
ALNYLAM PHARMACEUTICALS, INC.	+25.40%	30.36B
ICON PUBLIC LIMITED COMPANY	+17.96%	27.61B
CELLTRION, INC.	-4.47%	28.7B
UNITED THERAPEUTICS CORPORATION	+50.73%	14.7B
MEDPACE HOLDINGS, INC.	+42.56%	13.51B
BIO-TECHNE CORPORATION	+1.46%	12.34B

Other Biotechnology & Medical Research